Compare ON & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ON | HLN |
|---|---|---|
| Founded | 1992 | 2022 |
| Country | United States | United Kingdom |
| Employees | 22670 | N/A |
| Industry | Semiconductors | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 42.8B |
| IPO Year | 2000 | 2021 |
| Metric | ON | HLN |
|---|---|---|
| Price | $74.33 | $10.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 1 |
| Target Price | ★ $65.29 | N/A |
| AVG Volume (30 Days) | 9.5M | ★ 10.2M |
| Earning Date | 05-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $5,878,300,000.00 | N/A |
| Revenue This Year | $7.93 | $6.55 |
| Revenue Next Year | $8.90 | $4.42 |
| P/E Ratio | $155.61 | ★ $49.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.56 | $8.65 |
| 52 Week High | $134.92 | $11.28 |
| Indicator | ON | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 35.44 | 56.43 |
| Support Level | $54.93 | $9.98 |
| Resistance Level | $102.64 | $10.23 |
| Average True Range (ATR) | 3.12 | 0.14 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 6.28 | 78.90 |
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and one of the largest suppliers of image sensors to the automotive market. Its chips sell into vehicle drivetrains, automotive safety systems, energy infrastructure, industrial automation, and data centers. Onsemi manufactures most of its products in-house, vertically integrated from design to production. Its sales are split between direct and distribution, and it holds a global manufacturing and customer footprint.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.